Firebrick Pharma (ASX:FRE) share price launches 165% following ...

Motley Fool Australia - 28 Jan 2022
Shares in virus-killing nasal spray developer, Firebrick Pharma Limited (ASX: FRE), opened 500% higher than its IPO offer price on its ASX float.

Firebrick Pharma Ltd (ASX: FRE)

The Motley Fool Australia - 31 Jan 2022

Firebrick Pharma (ASX

Firebrick Pharma (ASX:FRE) share price launches 165% following ...

ASX Health Stocks: Firebrick skyrockets 80pc on Nasodine’s US launch

Despite Recent Gains, Firebrick Pharma Insiders Are Still Down AU$99k

Firebrick Pharma Lists New Securities on ASX

ASX Health Stocks: Sigma-Chemist Warehouse merger under ACCC scrutiny

Firebrick Pharma says Nasodine Phase 2 COVID-19 trial results published

Firebrick Pharma Ltd (ASX: FRE)

“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nas ...

Firebrick Pharma (ASX: FRE) down 82% - the cold cure works less well than plain water

Firebrick Pharma says nasal spray achieved endpoint in Covid-19 trial

In Case You Missed It: Firebrick back after review points to ‘inaccuracies in trial efficacy data’

ASX Health Stocks: EBR stumbles 11pc after warning of FDA delay; Firebrick’s trial data shows ‘ ...

ASX Health Stocks: Firebrick to start Phase 3 trial on common cold spray, MGC Pharma surges 30pc on FDA li ...

Q+A: Firebrick Pharma is just weeks away from finding out if it has cracked a cure for the common cold

What's New

Get in touch